Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK2B | Q14289 | 1/20 | 0.50 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | RXRA | P19793 | 1/20 | 0.47 |
| ▸ | RXRB | P28702 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MITF | O75030 | 1/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11843856 | 0.98 | PTK2B (0.49) | PTK2BCXCL8BCHEHPGDTP53 | |
| SCHEMBL2947498 | 0.84 | PTK2B (0.51) | PTK2BCXCL8BCHEHPGDTP53 | |
| SCHEMBL56863 | 0.84 | PTK2B (0.51) | PTK2BCXCL8BCHEHPGDTP53 | |
| SCHEMBL29450644 | 0.84 | PTK2B (0.51) | PTK2BCXCL8BCHEHPGDTP53 | |
| SCHEMBL1637925 | 0.84 | AKR1C3 (0.47) | PTK2BCXCL8BCHEHPGDTP53 | |
| SCHEMBL143632 | 0.83 | KDM4E (0.46) | HPGDTP53ALDH1A1MAPTKMT2A | |
| SCHEMBL100191 | 0.83 | TSHR (0.50) | CXCL8TP53HTTALDH1A1MAPT | |
| SCHEMBL695666 | 0.82 | PTK2B (0.50) | PTK2BCXCL8BCHEHPGDTP53 | |
| SCHEMBL3199958 | 0.82 | PTK2B (0.50) | PTK2BCXCL8BCHEHPGDTP53 | |
| SCHEMBL5706002 | 0.81 | KMT2A (0.63) | PTK2BHPGDTP53RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115677999-B | Polycarbonate and preparation method and application thereof | 华为技术有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117645540-A | Preparation method of chlorophenoxycarboxylate | 山东润博生物科技有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-117466730-A | Preparation method of phenoxy carboxylate herbicide | 山东润博生物科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116789542-A | Preparation method and post-treatment method of chlorophenoxycarboxylic acid herbicide | 山东润博生物科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-113968963-B | Polycarbonate and preparation method and application thereof | 万华化学集团股份有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-114085368-B | Polycarbonate and preparation method and application thereof | 万华化学集团股份有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-111111696-B | Solvothermal method for synthesizing sulfide-TiO with regular morphology in one pot2Method for compounding nanostructures and use thereof | 中南民族大学 | 2022-07-01 | — | — | CN | claimed |
| CN-114085368-A | Polycarbonate and preparation method and application thereof | 万华化学集团股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| US-11078150-B2 | Preparation method for chlorophenoxycarboxylate | SHANDONG RAINBOW BIOTECH CO., LTD. (CN) | 2021-08-03 | — | — | US | claimed |
| US-20210002201-A1 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | SHANDONG RAINBOW BIOTECH CO., LTD. (CN) | 2021-01-07 | — | — | US | claimed |
| WO-2004030617-A2 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2004-04-15 | — | — | WO | claimed |
| US-20040062748-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | claimed |
| US-20040062746-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | claimed |
| US-20030012777-A1 | Polymer conjugates of proteinases | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2003-01-16 | — | — | US | claimed |
| WO-2003002716-A2 | POLYMER STABILIZED PROTEINASES | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2003-01-09 | — | — | WO | claimed |
| US-20020016293-A1 | Flavopiridol drug combinations and methods with reduced side effects | NIH - DEITR | 2002-02-07 | — | — | US | claimed |
| WO-2001080896-A2 | FLAVOPIRIDOL DRUG COMBINATIONS AND METHODS WITH REDUCED SIDE EFFECTS | ARCH DEVELOPMENT CORPORATION (US) | 2001-11-01 | — | — | WO | claimed |
| US-5786344-A | ADMINISTERING WITH AGENT WHICH INCREASES ACTIVITY OF GLUCURONOSYLTRANSFERASE OR DECREASES ACTIVITY OF BILIARY TRANSPORT PROTEIN | ARCH DEVELOPMENT CORPORATION (US) | 1998-07-28 | — | — | US | claimed |
| EP-0768895-A1 | CAMPTOTHECIN DRUG COMBINATIONS AND MEDICAMENTS WITH REDUCED SIDE EFFECTS | ARCH DEVELOPMENT CORPORATION (US) | 1997-04-23 | — | — | EP | claimed |
| WO-1996001127-A1 | CAMPTOTHECIN DRUG COMBINATIONS AND MEDICAMENTS WITH REDUCED SIDE EFFECTS | ARCH DEVELOPMENT CORPORATION (US) | 1996-01-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016293-A1 | Flavopiridol drug combinations and methods with reduced side effects | UGT1A1, UGT1A3, CYP7A1 | PTK2B 4535/4885CXCL8 3199/4885BCHE 295/4885 |
| US-20210002201-A1 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | CBLB, CBL, CBLC | PTK2B 853/4885CXCL8 3994/4885BCHE 233/4885 |
| US-20040062748-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | CD14, HLA-C, HLA-A | PTK2B 2151/4885CXCL8 943/4885BCHE 578/4885 |
| US-20040062746-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | CD14, HLA-C, HLA-A | PTK2B 2151/4885CXCL8 943/4885BCHE 578/4885 |
| US-11078150-B2 | Preparation method for chlorophenoxycarboxylate | CBLB, CBL, CBLC | PTK2B 853/4885CXCL8 3994/4885BCHE 233/4885 |
| US-20030012777-A1 | Polymer conjugates of proteinases | PRNP, PRSS3, PRSS1 | PTK2B 4700/4885CXCL8 3361/4885BCHE 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.